Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02362594
Brief Title: Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

First Submitted : February 9, 2015
First Submitted that Met QC Criteria : February 9, 2015
First Posted : February 13, 2015 (Estimate)

Results First Submitted : December 10, 2018
Results First Submitted that Met QC Criteria : December 10, 2018
Results First Posted : January 4, 2019

Last Update Submitted that Met QC Criteria : September 25, 2020
Last Update Posted : October 20, 2020